Global Blood Therapeutics (GB:0IVZ)

Global Blood Therapeutics (0IVZ) Share Price & Analysis


0IVZ Stock Chart & Stats

Day’s Range$68.48 - $68.48
52-Week Range― - ―
Previous Close$68.48
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding67,476,179
10 Day Avg. Volume92
30 Day Avg. Volume152
Standard Deviation13.25
Financial Highlights & Ratios
Price to Book (P/B)39.05
Price to Sales (P/S)18.18
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-24.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside0.15% Upside
Rating ConsensusHold
Number of Analyst Covering14




What was Global Blood Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Global Blood Therapeutics’s market cap?
Currently, no data Available
When is Global Blood Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Global Blood Therapeutics’s earnings last quarter?
Currently, no data Available
Is Global Blood Therapeutics overvalued?
According to Wall Street analysts Global Blood Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Global Blood Therapeutics pay dividends?
    Global Blood Therapeutics does not currently pay dividends.
    What is Global Blood Therapeutics’s EPS estimate?
    Global Blood Therapeutics’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Global Blood Therapeutics have?
    Currently, no data Available
    What happened to Global Blood Therapeutics’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Global Blood Therapeutics?
    Among the largest hedge funds holding Global Blood Therapeutics’s share is Perceptive Advisors LLC. It holds Global Blood Therapeutics’s shares valued at 96M.


      Global Blood Therapeutics Stock Smart Score

      The Global Blood Therapeutics Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      Global Blood Therapeutics

      Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Gilead Sciences
      Vertex Pharmaceuticals

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis